B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

An international clinical trial led by WashU Medicine researchers shows an innovative CAR-T cell immunotherapy is promising ...

Two years ago, we introduced you to Tobias and his mother, Charity DeLeon—a brave family thrust into a battle they never ...

The autologous immunotherapy consists of the patient’s own T cells engineered to express a chimeric antigen receptor that ...

Huntsman Cancer Institute completed the first successful allogeneic stem cell transplant using cells from a deceased donor.

Analyzing DNA methylation patterns in leukemic cells is helping doctors better assess risk and tailor treatments, making ...

Researchers sought to determine whether venetoclax plus low-intensity chemotherapy would be effective in adult patients with ALL.

The Fonda Fultonville School District is mourning the loss of a middle school student who died earlier this week.

In recent years, the therapeutic landscape for hematological malignancies has undergone a profound transformation, driven by ...

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.